Those mesothelioma patients that have already undergone a chemotherapeutic course course of pemetrexed may gain benefits from undergoing a second course with a different medication known as vinorelbine. Though Pemetrexed and a platinum-based medication called cisplatin are the most traditional first-line course of chemotherapy treatment used in mesothelioma patients, physicians have found that the use
A study presented at the 15th World Conference on Lung Cancer has provided controversial information. It indicates that when the patients who are deemed healthiest among mesothelioma victims undergo surgery, it does not provide an appreciable improvement in the patient’s survival rates. The study was conducted in Italy and included data from almost 1,400 patients
The results of a new study were released by researchers from the Queen Mary’s Barts Cancer Institute in London, and they offer great promise for those hoping to slow down or stop the growth of mesothelioma tumors. The results, which revolved around the application of a new drug that is designed to deprive the tumor
A recent study conducted by scientists at Papworth Hospital in Cambridge, United Kingdom,indicated that an invasive keyhole surgery called video-assisted thoracoscopic surgery, or VATS, does nothing to extend mesothelioma patients’ survival rates but does make a considerable improvement in their quality of life. The study was presented at the 15th World Conference on Lung Cancer.
For those who work in health advocacy, and particularly those who focus on asbestos-related diseases, news of loss and waste as a result of exposure to asbestos is nothing new. But a recent report by the World Health Organization (WHO) shocked even those who work with bad news every day. The report, which was published
The USS Charles R. Ware (DD-865) was a Gearing-class destroyer launched and commissioned in 1945. The ship served throughout the Cold War era, participating in numerous NATO operations and combat missions in Vietnam. Service aboard the ship exposed crew members to dangerous asbestos-containing materials that were integrated throughout its construction, leading to many veterans’ development of malignant mesothelioma and other asbestos-related diseases.
For the last three years, since William Durbec was diagnosed with malignant mesothelioma, he and his wife, Victoria, have been seeking justice for the harm they’ve both suffered. Last month, a New York jury awarded Mr. Durbec $78 million for his past and future pain and suffering, and an additional $39 million to Mrs. Durbec
A collaborative study conducted by the renowned Sbarro Health Research Organization (SHRO) and the University of Siena in Italy has helped scientists better understand how asbestos exposure can lead to malignant pleural mesothelioma, the rare and deadly form of cancer that affects the lining of the lungs. The research provides an answer to the long-standing
Asbestos Corporation Ltd. is a Canadian mining company that has been named as a defendant in thousands of mesothelioma and asbestos-related disease lawsuits in recent years. Founded in 1925 and headquartered in Thetford Mines, Quebec, the company has made a practice of refusing to participate in discovery proceedings in lawsuits filed against it, arguing that
The people being diagnosed with mesothelioma today had no idea they were being put at risk decades ago: Though asbestos companies were aware of their products’ toxicity, they issued no warnings and did nothing to protect employees or consumers. Though the rare form of cancer can’t be stopped from forming, those with known exposures can